Glial Cell Expression of PD-L1

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2019 Apr 17

PMID 30987269

Citations 19

Authors

Priyanka Chauhan

James R Lokensgard

Affiliations

Soon will be listed here.

Abstract

The programmed death (PD)-1/PD-L1 pathway is a well-recognized negative immune checkpoint that results in functional inhibition of T-cells. Microglia, the brain-resident immune cells are vital for pathogen detection and initiation of neuroimmune responses. Moreover, microglial cells and astrocytes govern the activity of brain-infiltrating antiviral T-cells through upregulation of PD-L1 expression. While T-cell suppressive responses within brain are undoubtedly beneficial to the host, preventing cytotoxic damage to this vital organ, establishment of a prolonged anti-inflammatory milieu may simultaneously lead to deficiencies in viral clearance. An immune checkpoint blockade targeting the PD-1: PD-L1 (B7-H1; CD274) axis has revolutionized contemporary treatment for a variety of cancers. However, the therapeutic potential of PD1: PD-L1 blockade therapies targeting viral brain reservoirs remains to be determined. For these reasons, it is key to understand both the detrimental and protective functions of this signaling pathway within the brain. This review highlights how glial cells use PD-L1 expression to modulate T-cell effector function and limit detrimental bystander damage, while still retaining an effective defense of the brain.

Citing Articles

The role of inhibitory immune checkpoint receptors in the pathogenesis of Alzheimer's disease.

Salminen A J Mol Med (Berl). 2024; 103(1):1-19.

PMID: 39601807 PMC: 11739239. DOI: 10.1007/s00109-024-02504-x.

Imaging PD-L1 in the brain-Journey from the lab to the clinic.

Dar D, Rodak M, Da Pieve C, Gorczewska I, Sharma G, Chmielik E Neuro Oncol. 2024; 27(2):567-582.

PMID: 39470381 PMC: 11812043. DOI: 10.1093/neuonc/noae190.

Comparative proteomic analysis of regenerative mechanisms in mouse retina to identify markers for neuro-regeneration in glaucoma.

Wang X, Fruhn L, Li P, Shi X, Wang N, Feng Y Sci Rep. 2024; 14(1):23118.

PMID: 39366989 PMC: 11452382. DOI: 10.1038/s41598-024-72378-z.

Tumor perfusion enhancement by focus ultrasound-induced blood-brain barrier opening to potentiate anti-PD-1 immunotherapy of glioma.

Shan H, Zheng G, Bao S, Yang H, Shrestha U, Li G Transl Oncol. 2024; 49:102115.

PMID: 39217852 PMC: 11402623. DOI: 10.1016/j.tranon.2024.102115.

Reconstitution of human microglia and resident T cells in the brain of humanized DRAGA mice.

Ghosh Roy S, Karim A, Brumeanu T, Casares S Front Cell Infect Microbiol. 2024; 14:1367566.

PMID: 38983114 PMC: 11231403. DOI: 10.3389/fcimb.2024.1367566.

References

Aloisi F . Immune function of microglia. Glia. 2001; 36(2):165-79. DOI: 10.1002/glia.1106. View

Eppihimer M, Gunn J, Freeman G, Greenfield E, Chernova T, Erickson J . Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells. Microcirculation. 2002; 9(2):133-45. PMC: 3740166. DOI: 10.1038/sj/mn/7800123. View

Iwai Y, Ishida M, Tanaka Y, Okazaki T, Honjo T, Minato N . Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc Natl Acad Sci U S A. 2002; 99(19):12293-7. PMC: 129438. DOI: 10.1073/pnas.192461099. View

Yamazaki T, Akiba H, Iwai H, Matsuda H, Aoki M, Tanno Y . Expression of programmed death 1 ligands by murine T cells and APC. J Immunol. 2002; 169(10):5538-45. DOI: 10.4049/jimmunol.169.10.5538. View

Liu B, Hong J . Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther. 2002; 304(1):1-7. DOI: 10.1124/jpet.102.035048. View

Wiendl H, Mitsdoerffer M, Schneider D, Chen L, Lochmuller H, Melms A . Human muscle cells express a B7-related molecule, B7-H1, with strong negative immune regulatory potential: a novel mechanism of counterbalancing the immune attack in idiopathic inflammatory myopathies. FASEB J. 2003; 17(13):1892-4. DOI: 10.1096/fj.03-0039fje. View

Rodig N, Ryan T, Allen J, Pang H, Grabie N, Chernova T . Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis. Eur J Immunol. 2003; 33(11):3117-26. DOI: 10.1002/eji.200324270. View

Wintterle S, Schreiner B, Mitsdoerffer M, Schneider D, Chen L, Meyermann R . Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis. Cancer Res. 2003; 63(21):7462-7. View

Blais V, Rivest S . Effects of TNF-alpha and IFN-gamma on nitric oxide-induced neurotoxicity in the mouse brain. J Immunol. 2004; 172(11):7043-52. DOI: 10.4049/jimmunol.172.11.7043. View

10.

Latchman Y, Liang S, Wu Y, Chernova T, Sobel R, Klemm M . PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. Proc Natl Acad Sci U S A. 2004; 101(29):10691-6. PMC: 489996. DOI: 10.1073/pnas.0307252101. View

11.

Magnus T, Schreiner B, Korn T, Jack C, Guo H, Antel J . Microglial expression of the B7 family member B7 homolog 1 confers strong immune inhibition: implications for immune responses and autoimmunity in the CNS. J Neurosci. 2005; 25(10):2537-46. PMC: 6725171. DOI: 10.1523/JNEUROSCI.4794-04.2005. View

12.

Cheeran M, Gekker G, Hu S, Palmquist J, Lokensgard J . T cell-mediated restriction of intracerebral murine cytomegalovirus infection displays dependence upon perforin but not interferon-gamma. J Neurovirol. 2005; 11(3):274-80. PMC: 7095405. DOI: 10.1080/13550280590952808. View

13.

Barber D, Wherry E, Masopust D, Zhu B, Allison J, Sharpe A . Restoring function in exhausted CD8 T cells during chronic viral infection. Nature. 2005; 439(7077):682-7. DOI: 10.1038/nature04444. View

14.

Bailey S, Carpentier P, McMahon E, Begolka W, Miller S . Innate and adaptive immune responses of the central nervous system. Crit Rev Immunol. 2006; 26(2):149-88. DOI: 10.1615/critrevimmunol.v26.i2.40. View

15.

Hori J, Wang M, Miyashita M, Tanemoto K, Takahashi H, Takemori T . B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts. J Immunol. 2006; 177(9):5928-35. DOI: 10.4049/jimmunol.177.9.5928. View

16.

Carter L, Leach M, Azoitei M, Cui J, Pelker J, Jussif J . PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis. J Neuroimmunol. 2006; 182(1-2):124-34. DOI: 10.1016/j.jneuroim.2006.10.006. View

17.

Lipp M, Brandt C, Dehghani F, Kwidzinski E, Bechmann I . PD-L1 (B7-H1) regulation in zones of axonal degeneration. Neurosci Lett. 2007; 425(3):156-61. DOI: 10.1016/j.neulet.2007.07.053. View

18.

Usui Y, Okunuki Y, Hattori T, Kezuka T, Keino H, Ebihara N . Functional expression of B7H1 on retinal pigment epithelial cells. Exp Eye Res. 2007; 86(1):52-9. DOI: 10.1016/j.exer.2007.09.007. View

19.

Jeong H, Lee Y, Seo S, Lee S, Park S, Lee J . Blocking of monocyte-associated B7-H1 (CD274) enhances HCV-specific T cell immunity in chronic hepatitis C infection. J Leukoc Biol. 2007; 83(3):755-64. DOI: 10.1189/jlb.0307168. View

20.

Ortler S, Leder C, Mittelbronn M, Zozulya A, Knolle P, Chen L . B7-H1 restricts neuroantigen-specific T cell responses and confines inflammatory CNS damage: implications for the lesion pathogenesis of multiple sclerosis. Eur J Immunol. 2008; 38(6):1734-44. DOI: 10.1002/eji.200738071. View